Junfang Xu, MD
Huadong Medicine Co., Ltd.
3
0
1
N/A
0
1
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (3)
Research Network
Collaboration Network
Research Areas & Affiliations
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Yanshan Huang, PhD
Zhejiang Doer Biologics Co., Ltd.
Shared therapeutic areas:
Worked with same sponsors:
Hongming Pan, MD,PhD
Sir Run Run Shaw Hospital
Shared therapeutic areas:
Worked with same sponsors:
Alexandra Cole, DHPharm
New Zealand Clinical Research (NZCR)
Shared therapeutic areas:
Worked with same sponsors:
Caicun Zhou, MD
Shanghai Pulmonary Hospital, Shanghai, China
Shared therapeutic areas:
Worked with same sponsors:
Yongliang Fang, PhD
Zhejiang Doer Biologics Co., Ltd.
Shared therapeutic areas:
Worked with same sponsors:
Yifan Zhai, MD, PhD
Ascentage Pharma Group Inc.
Shared therapeutic areas:
You Lu, MD
West China Hospital
Shared therapeutic areas:
Barbara Murphy, MD
Vanderbilt-Ingram Cancer Center
Shared therapeutic areas:
Staci M Peron, Ph.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Jianmin Fang, Ph.D
RemeGen Co., Ltd.
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (3)
Showing 3 of 3 trials
Evaluate the Safety, Tolerability, Pharmacokinetics of DR30206 in Patients With Advanced or Metastatic Solid Tumors
A First in Human (FIH) Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DR10624
A Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of DR30303 in Patients With Advanced Solid Tumors
All 3 trials loaded